BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MultiStem: Completed Phase I enrollment

Athersys completed enrollment of patients with acute leukemia, chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS) in an open-label, dose-escalation Phase I trial evaluating single and multiple doses of IV MultiStem following allogeneic hematopoietic stem...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >